Home Newsfeeds Keybanc Downgrades Westlake to Underweight, Announces $90 Price Target

Keybanc Downgrades Westlake to Underweight, Announces $90 Price Target

Keybanc analyst Aleksey Yefremov downgrades Westlake (NYSE:WLK) from Sector Weight to Underweight and announces $90 price target.

byBenzinga Newsdesk

August 29, 2022

1 minute read

Keybanc analyst Aleksey Yefremov downgrades Westlake (NYSE:WLK) from Sector Weight to Underweight and announces $90 price target.

BioMarin’s Roctavian US Launch: Focus on Commercial Strategy Amid EU Failures, Analyst Points Out

By Vandana Singh

June 30, 2:41 PM

On Thursday, The FDA approved BioMarin Pharmaceutical Inc's (NASDAQ: BMRN) Roctavian (valoctocogene roxaparvovec-rvox) gene therapy for adults

BMRN

Analyst Ratings

Key Takeaways From Utz Brands Analyst Ratings

By Benzinga Insights

December 18, 11:39 AM

Discover the latest analyst ratings for Utz Brands (NYSE:UTZ) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat…

UTZ

This May Be A No-Brainer: $11 Regional Bank Stock With 7% Dividend Yield

By AJ Fabino

April 28, 11:38 AM

Despite the recent volatility in regional bank stocks, some are still worth considering for their attractive valuation and dividend yield. KeyCorp (NYSE: KEY), for instance, caught the attention of analysts including Citigroup and DA Davidson, who rate the stock as a Buy.

KEY